Evidence map›Paper›PMID 37508305›Full record

ArticleAntibiotics (Basel, Switzerland)2023

High Emergence of Multidrug-Resistant Sequence Type 131 Subclade C2 among Extended-Spectrum β-Lactamase (ESBL)-Producing

Ján Koreň, Michal Andrezál, Elham Ozaee, Hana Drahovská, Martin Wawruch, Adriána Liptáková, Tibor Maliar

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Evaluation ofFrontiers in veterinary science · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ján KoreňInstitute of Microbiology, Faculty of Medicine, Comenius University, University Hospital Bratislava, 81108 Bratislava, Slovakia.
Michal AndrezálDepartment of Molecular Biology, Faculty of Natural Sciences, Comenius University, 84215 Bratislava, Slovakia.
Elham OzaeeDepartment of Molecular Biology, Faculty of Natural Sciences, Comenius University, 84215 Bratislava, Slovakia.
Hana DrahovskáDepartment of Molecular Biology, Faculty of Natural Sciences, Comenius University, 84215 Bratislava, Slovakia.
Martin WawruchInstitute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University, 81108 Bratislava, Slovakia.ORCID 0000-0001-7672-1574
Adriána LiptákováInstitute of Microbiology, Faculty of Medicine, Comenius University, University Hospital Bratislava, 81108 Bratislava, Slovakia.ORCID 0000-0002-1677-0590
Tibor MaliarDepartment of Chemistry, Faculty of Natural Sciences, University of Ss. Cyril and Methodius in Trnava, 91701 Trnava, Slovakia.ORCID 0000-0003-2894-636X
Comenius University Bratislava · SKUniversity Hospital Bratislava · SKUniversity of Ss. Cyril and Methodius in Trnava · SK

Funding

Operational Program Integrated Infrastructure ITMS: 313011T431
6 · The paper itself

Abstract

The expansion of sequence type 131 (ST131) extended-spectrum β-lactamase (ESBL)-producing

Indexed as

antimicrobial resistanceclade and subcladeESBL-producing Escherichia colihealthcare facilitiesST131

Identifiers

PMID37508305
PMCPMC10376107
OpenAlexW4385069401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.